My group at the European Research Institute for the Biology of Ageing has recently formed an alliance with ROME Therapeutics (of Boston, MA). As part of the new R&D collaboration we will study the interactome-level and biochemical effects of various drugs (including reverse transcriptase inhibitors) on LINE-1 retrotransposons. LINE-1 is increasingly recognized for its pathobiological roles in human cancers and auto-immunity, among others. Therapeutics designed to block LINE-1 are among the foundational goals of ROME Tx and other biotech companies emerging in this space.
Experience in RNA biology and/or proteomics are desired but all enthusiastic, accomplished applicants with a solid basis in cell and molecular biology will be considered. The position is funded for two years with the possibility of extension by another two, pending results and funding.
The cost of living in Groningen is low relative to the pay-scale, providing a good quality of life in a vibrant university city in the north of NL – tax-break incentives to move to NL are available. Groningen is well connected by train to Amsterdam and Schiphol airport to reach any international destination with ease. Be prepared to live your life from the seat of a bicycle. I am happy to provide color comments on the life style here.
Applications and inquiries (formal or informal) about the group and position should be sent to me at firstname.lastname@example.org. To be formally considered, please provide a brief description of your interest in the position, highlight your major applicable skills, attach a current CV, and provide contact info for two professional references.
http://www.macromolecule.fun (our group’s research web page)
Some recent, relevant publications from our group in the area of the project:
Tagged as: Life Sciences
The Battaglia lab at the Donders Institute for Brain, Cognition, and Behaviour, Radboud University Nijmegen is looking for one talented...Apply